{
  "name": "Vertex Pharmaceuticals",
  "slug": "vertex-pharmaceuticals",
  "ticker": "VRTX",
  "fetched_at": "2025-10-03T12:21:47.773835+00:00",
  "news": [
    {
      "title": "Final Trades: ServiceNow, Vertex Pharmaceuticals and the IJR - CNBC",
      "link": "https://news.google.com/rss/articles/CBMiowFBVV95cUxNeEtMbmRVLTdWTFhkTEFwN3N6THh4THpHa0piLXRuS1RDZkRDbWZUV3Y5enMydWNCYUNjRm9rQmNUZHhYQ2ZzQVNzaDBoWUk5aWV4LXB3Zk5sbjUxNEZSdnBNdEZvVngweDlCNlBHcmJLUHpEM0VUZXF6Q2dFNFpVU3MxQXhMVlAySEpGc0VkZ3JMUmV1MHZpMVpPNnJYZmdwZDBr?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiowFBVV95cUxNeEtMbmRVLTdWTFhkTEFwN3N6THh4THpHa0piLXRuS1RDZkRDbWZUV3Y5enMydWNCYUNjRm9rQmNUZHhYQ2ZzQVNzaDBoWUk5aWV4LXB3Zk5sbjUxNEZSdnBNdEZvVngweDlCNlBHcmJLUHpEM0VUZXF6Q2dFNFpVU3MxQXhMVlAySEpGc0VkZ3JMUmV1MHZpMVpPNnJYZmdwZDBr?oc=5\" target=\"_blank\">Final Trades: ServiceNow, Vertex Pharmaceuticals and the IJR</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">CNBC</font>",
      "published": "2025-10-02T17:11:00+00:00",
      "source": "CNBC"
    },
    {
      "title": "Vertex Pharmaceuticals (VRTX) Highlights Pipeline Progress at BofA Global Healthcare Conference - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMimAFBVV95cUxONmJqX3hWcjdCTm1VbFlDN1dUTVd2SHVfcW53cGVadDhOeDJMQ2xWZkItR0pHbGFNcG1RblZabmptWWNJR29ubFNuQ0tmSnBnTmlrNXd4bUJkbHQzMkJiSzJ0UUYzeW9RUDhCRTgycThoZHRINkVPLWdSdXdZVmc2c0tvZk1tY3ExRGRTUVNOb3o3Z1hnUWRNeA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMimAFBVV95cUxONmJqX3hWcjdCTm1VbFlDN1dUTVd2SHVfcW53cGVadDhOeDJMQ2xWZkItR0pHbGFNcG1RblZabmptWWNJR29ubFNuQ0tmSnBnTmlrNXd4bUJkbHQzMkJiSzJ0UUYzeW9RUDhCRTgycThoZHRINkVPLWdSdXdZVmc2c0tvZk1tY3ExRGRTUVNOb3o3Z1hnUWRNeA?oc=5\" target=\"_blank\">Vertex Pharmaceuticals (VRTX) Highlights Pipeline Progress at BofA Global Healthcare Conference</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-10-02T20:55:32+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Attention nephrologists! New diagnostic codes for APOL1-mediated kidney disease - Vertex Pharmaceuticals",
      "link": "https://news.google.com/rss/articles/CBMipwFBVV95cUxOTmthZXRhMnViaWQwSWZ4UFJMSVVScEI0NWhmaXdHaTJUSzI1SUxSaVh6V0RyLVNqSHhnSGtNVmt1NVM2cWQ4NlE1RmYzMHd3UTF3d1VOY3dhZjVzbkV1eG1lRjJOOVZvWkRWR19OZ1VtdTJEU2xUNEVTYUoxSENZcGJpZHI2NW44U0NoNVRkQ0t1TkhuU3JqUFQ1ZWVUc01FSUNFSklWRQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMipwFBVV95cUxOTmthZXRhMnViaWQwSWZ4UFJMSVVScEI0NWhmaXdHaTJUSzI1SUxSaVh6V0RyLVNqSHhnSGtNVmt1NVM2cWQ4NlE1RmYzMHd3UTF3d1VOY3dhZjVzbkV1eG1lRjJOOVZvWkRWR19OZ1VtdTJEU2xUNEVTYUoxSENZcGJpZHI2NW44U0NoNVRkQ0t1TkhuU3JqUFQ1ZWVUc01FSUNFSklWRQ?oc=5\" target=\"_blank\">Attention nephrologists! New diagnostic codes for APOL1-mediated kidney disease</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Vertex Pharmaceuticals</font>",
      "published": "2025-10-01T13:45:26+00:00",
      "source": "Vertex Pharmaceuticals"
    },
    {
      "title": "Final Trades: ServiceNow, Vertex Pharmaceuticals and the IJR - MSN",
      "link": "https://news.google.com/rss/articles/CBMi1AFBVV95cUxOV3M4UUF2YWNQX2lzRFoyMXBPVm5sM1ZwUW90RWpmcDNxU3Zvb2VJUmc5ZmZqQnp6dWZoRGMwVjhjSlRKY180WDc4enhCRFJhT2tEQ21GMHNkZDZ5YW1QZnRiLWxWRXk0cFljOHJubmlIQkZCOFN0WGZJaHRkaGljOThLc0hIOU9ubUUyYURPY3BVZFdURE9ESGVmMFkwU0dRdThMbUNoYlpVa19uWjQ0aWJwN0wxckNpREZxZkVKSnluai1sRGlwTXNWZURPTHFGX0J6WQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi1AFBVV95cUxOV3M4UUF2YWNQX2lzRFoyMXBPVm5sM1ZwUW90RWpmcDNxU3Zvb2VJUmc5ZmZqQnp6dWZoRGMwVjhjSlRKY180WDc4enhCRFJhT2tEQ21GMHNkZDZ5YW1QZnRiLWxWRXk0cFljOHJubmlIQkZCOFN0WGZJaHRkaGljOThLc0hIOU9ubUUyYURPY3BVZFdURE9ESGVmMFkwU0dRdThMbUNoYlpVa19uWjQ0aWJwN0wxckNpREZxZkVKSnluai1sRGlwTXNWZURPTHFGX0J6WQ?oc=5\" target=\"_blank\">Final Trades: ServiceNow, Vertex Pharmaceuticals and the IJR</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MSN</font>",
      "published": "2025-10-02T17:30:56+00:00",
      "source": "MSN"
    },
    {
      "title": "Vertex Pharmaceuticals (VRTX) Receives Raised Price Target from Citigroup | VRTX Stock News - GuruFocus",
      "link": "https://news.google.com/rss/articles/CBMixAFBVV95cUxQaVAzMTFyMEs0RlhLbkhENkhrOWJOT3lYUDhFNGpvdlplTW9leVp2b0ozSUJNVl9nNXZVd19SZ01pTDhwZlUzeW90ejlFV2VPaENNaTZhV2tuSVluWVFXZEZ6ZzdqMWMwYkE5RVZIWUtuNnlTRXdvaFJyR1dTSnFxcHNrNTJtWV9vbW52TFQ1aGtiak1vNUFqeWxrUi10RG4zLXpQd1lIUzZhMk5aOURlSEFzVzZDNzg2eWhmQ0UxS19DNVJJ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMixAFBVV95cUxQaVAzMTFyMEs0RlhLbkhENkhrOWJOT3lYUDhFNGpvdlplTW9leVp2b0ozSUJNVl9nNXZVd19SZ01pTDhwZlUzeW90ejlFV2VPaENNaTZhV2tuSVluWVFXZEZ6ZzdqMWMwYkE5RVZIWUtuNnlTRXdvaFJyR1dTSnFxcHNrNTJtWV9vbW52TFQ1aGtiak1vNUFqeWxrUi10RG4zLXpQd1lIUzZhMk5aOURlSEFzVzZDNzg2eWhmQ0UxS19DNVJJ?oc=5\" target=\"_blank\">Vertex Pharmaceuticals (VRTX) Receives Raised Price Target from Citigroup | VRTX Stock News</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">GuruFocus</font>",
      "published": "2025-10-02T19:00:01+00:00",
      "source": "GuruFocus"
    },
    {
      "title": "TIME100 Most Influential Companies 2025: Vertex Pharmaceuticals - Time Magazine",
      "link": "https://news.google.com/rss/articles/CBMiiwFBVV95cUxQVkY3MnJaQ3p3Mk5LZGVBRXhDY0ZmaF9CS21MZWJSb01RRTNUN0JHUE9lTGRrckh6QnkxUGhXcm1yNk81WmM5aVdxZVdTdEFTMTBaN0E0MndpNHRLWjBJd2RrZ09JT3ZDaE04d21ucmVkcnl4aGFIcFlaN1QxcGtiT1lYQ2ppX202b2pr?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiiwFBVV95cUxQVkY3MnJaQ3p3Mk5LZGVBRXhDY0ZmaF9CS21MZWJSb01RRTNUN0JHUE9lTGRrckh6QnkxUGhXcm1yNk81WmM5aVdxZVdTdEFTMTBaN0E0MndpNHRLWjBJd2RrZ09JT3ZDaE04d21ucmVkcnl4aGFIcFlaN1QxcGtiT1lYQ2ppX202b2pr?oc=5\" target=\"_blank\">TIME100 Most Influential Companies 2025: Vertex Pharmaceuticals</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Time Magazine</font>",
      "published": "2025-06-26T07:00:00+00:00",
      "source": "Time Magazine"
    },
    {
      "title": "1 Reason Wall Street Is Obsessed With Vertex Pharmaceuticals - The Motley Fool",
      "link": "https://news.google.com/rss/articles/CBMimAFBVV95cUxPSHpCZ2ZiTk5nRk1CRHNrOXM3VlpibEFXcng3SzBzSmh3NktLSkJkN3haU1NObnZ0cXlRRUVMa0d2YUFVTnpxb0xDREZJWkJYS2RUOFZfeTgxZGxLZ2VNd2RETXBVVnJMeXFQcHNzMzFGR25VSXlQbkJydXBkMFZZRkw0Zm4tNkMtZmtKREptQm5IbVRnZVlCdg?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMimAFBVV95cUxPSHpCZ2ZiTk5nRk1CRHNrOXM3VlpibEFXcng3SzBzSmh3NktLSkJkN3haU1NObnZ0cXlRRUVMa0d2YUFVTnpxb0xDREZJWkJYS2RUOFZfeTgxZGxLZ2VNd2RETXBVVnJMeXFQcHNzMzFGR25VSXlQbkJydXBkMFZZRkw0Zm4tNkMtZmtKREptQm5IbVRnZVlCdg?oc=5\" target=\"_blank\">1 Reason Wall Street Is Obsessed With Vertex Pharmaceuticals</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Motley Fool</font>",
      "published": "2025-09-15T07:00:00+00:00",
      "source": "The Motley Fool"
    },
    {
      "title": "Vertex Pharmaceuticals (VRTX) Exceeds Market Returns: Some Facts to Consider - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMikgFBVV95cUxPVkcwZ0tHX195ejNMbVpILUs0MjZKQWZzZGdyWmJ6bjg2aWZNRl9UWDlJN0t1UDVIYlBRNGxSRWdDYU02RFdUT0RoWm40MGR1WnQ3MHR5WHNMR2wwdjM2SnE3T2xjcm12TVQ4QVQ2YnJ4UGNKdUdpMTlGeEFpQ0dmd0FMSUozOXY1NmJfaEZEOEpaUQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMikgFBVV95cUxPVkcwZ0tHX195ejNMbVpILUs0MjZKQWZzZGdyWmJ6bjg2aWZNRl9UWDlJN0t1UDVIYlBRNGxSRWdDYU02RFdUT0RoWm40MGR1WnQ3MHR5WHNMR2wwdjM2SnE3T2xjcm12TVQ4QVQ2YnJ4UGNKdUdpMTlGeEFpQ0dmd0FMSUozOXY1NmJfaEZEOEpaUQ?oc=5\" target=\"_blank\">Vertex Pharmaceuticals (VRTX) Exceeds Market Returns: Some Facts to Consider</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-10-02T22:00:07+00:00",
      "source": "Yahoo Finance"
    }
  ],
  "product_launches": [
    {
      "title": "Strong Product Launches and Upbeat Guidance Could Be a Game Changer for Vertex Pharmaceuticals (VRTX) - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMijgFBVV95cUxNOFZFNHZzSk1rSnJWVTEwWExLd1FvWVBPUkVkTV9TRG1oUWdTbWgzbWNkdlA3MkVLNmVra3NUUWhBQWFXZ3c5LVNxZFRkWDhkMUZ1QVlUXzg3ZEZwOHY3TTRjMEYxUjlwZFhYVW84QUVXX0lQaTZVbDN4Qk5WM1NQX0EwSVJXZ2piZXl4d3ZB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMijgFBVV95cUxNOFZFNHZzSk1rSnJWVTEwWExLd1FvWVBPUkVkTV9TRG1oUWdTbWgzbWNkdlA3MkVLNmVra3NUUWhBQWFXZ3c5LVNxZFRkWDhkMUZ1QVlUXzg3ZEZwOHY3TTRjMEYxUjlwZFhYVW84QUVXX0lQaTZVbDN4Qk5WM1NQX0EwSVJXZ2piZXl4d3ZB?oc=5\" target=\"_blank\">Strong Product Launches and Upbeat Guidance Could Be a Game Changer for Vertex Pharmaceuticals (VRTX)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-08-22T07:00:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Vertex Pharmaceuticals: I'm Downgrading To Hold On Drug Pricing, Pipeline Concerns - Seeking Alpha",
      "link": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxOQzRYUXFRSkhaTzlvRWhZSDFkVWs5RlhYNUV4TURuR2NmNFB6U2tvZEpYdFpwZ2VWUk5TekNMQ2tFMUdVS29FMWJBeXI4MW1zcFQzYk83MFRoOEFIdlA4QjJBLWJMZllBazJJX0JYbDdvVXJEZGJiYklTS09YUkNEXzJUbWxmVnZWLUdDcG8yeDJWb2xGcnFqSEwybW9HYWdqWV93SElPS1BqZGFMc0s4ZzFYcjhGaXV1?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiuAFBVV95cUxOQzRYUXFRSkhaTzlvRWhZSDFkVWs5RlhYNUV4TURuR2NmNFB6U2tvZEpYdFpwZ2VWUk5TekNMQ2tFMUdVS29FMWJBeXI4MW1zcFQzYk83MFRoOEFIdlA4QjJBLWJMZllBazJJX0JYbDdvVXJEZGJiYklTS09YUkNEXzJUbWxmVnZWLUdDcG8yeDJWb2xGcnFqSEwybW9HYWdqWV93SElPS1BqZGFMc0s4ZzFYcjhGaXV1?oc=5\" target=\"_blank\">Vertex Pharmaceuticals: I'm Downgrading To Hold On Drug Pricing, Pipeline Concerns</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>",
      "published": "2025-09-24T18:36:55+00:00",
      "source": "Seeking Alpha"
    },
    {
      "title": "Vertex tops estimates on cystic fibrosis treatment strength, new products - Reuters",
      "link": "https://news.google.com/rss/articles/CBMi2AFBVV95cUxQV1RfcWFhZlB4RnlGTUNfYlJTOEFKaHREZHlEeV9GVHpnaW1zRDliVlMtX3dWdjZkS2RNRWhZaXc0NmdVcW10bVhmQV9NNlh3b3IwckhEME9rTFlIci1hRDF4RlFzRWprOWFTdjlVV1d4dVpIaVFGWXBiWF9tbnJmcFEydUxiNDF1TVJfLTI4QmtvcnIwWVhYd3hNTno2aFhpZF9WNFZjX3lJLVVsNjZfcWZOVTVzU2lXYzV1cmw0bDRpTUFiWjJLUElvRk15d1RKLWJnQy10MmU?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi2AFBVV95cUxQV1RfcWFhZlB4RnlGTUNfYlJTOEFKaHREZHlEeV9GVHpnaW1zRDliVlMtX3dWdjZkS2RNRWhZaXc0NmdVcW10bVhmQV9NNlh3b3IwckhEME9rTFlIci1hRDF4RlFzRWprOWFTdjlVV1d4dVpIaVFGWXBiWF9tbnJmcFEydUxiNDF1TVJfLTI4QmtvcnIwWVhYd3hNTno2aFhpZF9WNFZjX3lJLVVsNjZfcWZOVTVzU2lXYzV1cmw0bDRpTUFiWjJLUElvRk15d1RKLWJnQy10MmU?oc=5\" target=\"_blank\">Vertex tops estimates on cystic fibrosis treatment strength, new products</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Reuters</font>",
      "published": "2025-08-04T07:00:00+00:00",
      "source": "Reuters"
    },
    {
      "title": "(suzetrigine), a First-in-Class Treatment for Adults With Moderate-to-Severe Acute Pain - Vertex Pharmaceuticals Newsroom",
      "link": "https://news.google.com/rss/articles/CBMivgFBVV95cUxQNGhZSnljSUNJSGJ4SzNPVXdNeXNncWRyT1dUWVY2VDVxWDFhamJGQUtSWlhJLVVJMmhSQjROckJNemJGZVlkY3ZmR0ZmYXBiX1J1ZHExdk1ZOW1wTWp5T1ZWa283c2RkYjdkUlgwMEtNejlNb3NJbVZJZlpyVmNweWptQ3dWeDAtV0NfVEJXNG5RU1pTZFRUY01hOEd0SXdwMXFTdEpGTnJTMklMX2NRUnBwUGhndjcyWUJzc0pn?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivgFBVV95cUxQNGhZSnljSUNJSGJ4SzNPVXdNeXNncWRyT1dUWVY2VDVxWDFhamJGQUtSWlhJLVVJMmhSQjROckJNemJGZVlkY3ZmR0ZmYXBiX1J1ZHExdk1ZOW1wTWp5T1ZWa283c2RkYjdkUlgwMEtNejlNb3NJbVZJZlpyVmNweWptQ3dWeDAtV0NfVEJXNG5RU1pTZFRUY01hOEd0SXdwMXFTdEpGTnJTMklMX2NRUnBwUGhndjcyWUJzc0pn?oc=5\" target=\"_blank\">(suzetrigine), a First-in-Class Treatment for Adults With Moderate-to-Severe Acute Pain</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Vertex Pharmaceuticals Newsroom</font>",
      "published": "2025-01-30T08:00:00+00:00",
      "source": "Vertex Pharmaceuticals Newsroom"
    },
    {
      "title": "Vertex lays out plan to increase access and launch non-opioid pain reliever Journavx - Fierce Pharma",
      "link": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxNSFE4SUNTM29jZVgzVWNDOWZ4UHU1cjFuNnQ4TG1Xak5hNjJhREVrM0xzTTUxaE1wZktyZ2N4OXVKZkFycmpLcmdGejJ4eVN2UThxOWZGLTJld2xkakt4YnpnSWFVb2RHcUkxZEdqUHVLeGdZOU9sajJ4MllETXBQT01nVVNFbmVwdW9aUXJFbXFzcXNNZjdEVTZNYTVYcTdnQzA2cXNmT3JHTlBFLWZ2UEdUT1czMm8t?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiuAFBVV95cUxNSFE4SUNTM29jZVgzVWNDOWZ4UHU1cjFuNnQ4TG1Xak5hNjJhREVrM0xzTTUxaE1wZktyZ2N4OXVKZkFycmpLcmdGejJ4eVN2UThxOWZGLTJld2xkakt4YnpnSWFVb2RHcUkxZEdqUHVLeGdZOU9sajJ4MllETXBQT01nVVNFbmVwdW9aUXJFbXFzcXNNZjdEVTZNYTVYcTdnQzA2cXNmT3JHTlBFLWZ2UEdUT1czMm8t?oc=5\" target=\"_blank\">Vertex lays out plan to increase access and launch non-opioid pain reliever Journavx</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Fierce Pharma</font>",
      "published": "2025-02-11T08:00:00+00:00",
      "source": "Fierce Pharma"
    }
  ],
  "stock": {
    "ticker": "VRTX",
    "currency": "USD",
    "latest": {
      "date": "2025-10-02",
      "close": 408.8500061035156
    },
    "history": [
      {
        "date": "2025-09-24",
        "close": 376.6199951171875
      },
      {
        "date": "2025-09-25",
        "close": 381.8699951171875
      },
      {
        "date": "2025-09-26",
        "close": 385.739990234375
      },
      {
        "date": "2025-09-29",
        "close": 395.30999755859375
      },
      {
        "date": "2025-09-30",
        "close": 391.6400146484375
      },
      {
        "date": "2025-10-01",
        "close": 404.2099914550781
      },
      {
        "date": "2025-10-02",
        "close": 408.8500061035156
      }
    ],
    "name": "Vertex Pharmaceuticals Incorpor"
  }
}